PROMONITOR FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS TREATED WITH ADALIMUMAB IN ENGLAND AND WALES

被引：0
|
作者：
Tikhonova, I. A. [1 ]
Bello, S. [1 ]
Salmon, A. [1 ]
Robinson, S. [1 ]
Hemami, Rezaei M. [1 ]
Haigh, R. C. [2 ]
Jani, M. [3 ]
McDonald, T. J. [1 ]
Hoyle, M. [1 ]
机构：
[1] Univ Exeter, Exeter, Devon, England
[2] Royal Devon & Exeter Hosp, Exeter, Devon, England
[3] Univ Manchester, Manchester, Lancs, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS68
引用
下载
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [1] Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
    I'Ami, Merel J.
    Marsman, Anneke F.
    Krieckaert, Charlotte L. M.
    Nurmohamed, Mike T.
    Ruwaard, Jill
    Visman, Ingrid M.
    Kneepkens, Eva L.
    Wolbink, Gertjan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] TAPERING OF ADALIMUMAB BASED ON THERAPEUTIC DRUG MONITORING IN RHEUMATOID ARTHRITIS
    l'Ami, M. J.
    Marsman, A. F.
    Krieckaert, C. L.
    Ruwaard, J.
    Kneepkens, E. L.
    Nurmohamed, M. T.
    Wolbink, G. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1012 - 1012
  • [3] Severe candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab
    Kobak, Senol
    Yilmaz, Hatice
    Guclu, Oguz
    Ogretmen, Zerrin
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2014, 1 (04) : 167 - 169
  • [4] Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis
    Llinares-Tello, Francisca
    Rosas, Jose
    de la Torre, Inmaculada
    Valor, Lara
    Barber, Xavier
    Miguel Senabre, Jose
    REUMATOLOGIA CLINICA, 2014, 10 (02): : 105 - 108
  • [5] A PREDICTION TOOL FOR DRUG MONITORING OF ADALIMUMAB IN RHEUMATOID ARTHRITIS.
    Ducourau, E.
    Ternant, D.
    Fuzibet, P.
    Lequerre, T.
    Paintaud, G.
    Le Loet, X.
    Goupille, P.
    Vittecoq, O.
    Mulleman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 427 - 427
  • [6] METHOTREXATE REDUCES IMMUNOGENICITY IN ADALIMUMAB TREATED RHEUMATOID ARTHRITIS PATIENTS
    Krieckaert, C.
    Nurmohamed, M. T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 101 - 102
  • [7] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [8] Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
    Herenius, M. M. J.
    Thurlings, R. M.
    Wijbrandts, C. A.
    Bennink, R. J.
    Dohmen, S. E.
    Voermans, C.
    Wouters, D.
    Izmailova, E. S.
    Gerlag, D. M.
    van Eck-Smit, B. L. F.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 1160 - 1162
  • [9] Therapeutic Drug Monitoring on Rheumatoid Arthritis Patients with Reduced Doses of Intravenous Tocilizumab
    Ruiz-Esquide, Virginia
    Bastida, Carla
    Pascal, Mariona
    Yague, Jordi
    Soy, Dolors
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] THERAPEUTIC DRUG MONITORING ON RHEUMATOID ARTHRITIS PATIENTS WITH REDUCED DOSES OF INTRAVENOUS TOCILIZUMAB
    Ruiz-Esquide, V.
    Bastida, C.
    Pascal, M.
    Yague, J.
    Soy, D.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 840 - 840
12345